Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

712 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.
Cuppen E, Elemento O, Rosenquist R, Nikic S, IJzerman M, Zaleski ID, Frederix G, Levin LÅ, Mullighan CG, Buettner R, Pugh TJ, Grimmond S, Caldas C, Andre F, Custers I, Campo E, van Snellenberg H, Schuh A, Nakagawa H, von Kalle C, Haferlach T, Fröhling S, Jobanputra V. Cuppen E, et al. Among authors: haferlach t. JCO Precis Oncol. 2022 Dec;6:e2200245. doi: 10.1200/PO.22.00245. JCO Precis Oncol. 2022. PMID: 36480778 Free PMC article. Review.
How I read an article that uses machine learning methods.
Nazha A, Elemento O, McWeeney S, Miles M, Haferlach T. Nazha A, et al. Among authors: haferlach t. Blood Adv. 2023 Aug 22;7(16):4550-4554. doi: 10.1182/bloodadvances.2023010140. Blood Adv. 2023. PMID: 37276509 Free PMC article. No abstract available.
Explainable AI identifies diagnostic cells of genetic AML subtypes.
Hehr M, Sadafi A, Matek C, Lienemann P, Pohlkamp C, Haferlach T, Spiekermann K, Marr C. Hehr M, et al. Among authors: haferlach t. PLOS Digit Health. 2023 Mar 15;2(3):e0000187. doi: 10.1371/journal.pdig.0000187. eCollection 2023 Mar. PLOS Digit Health. 2023. PMID: 36921004 Free PMC article.
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.
Fuchs SNR, Stalmann USA, Snoeren IAM, Bindels E, Schmitz S, Banjanin B, Hoogenboezem RM, van Herk S, Saad M, Walter W, Haferlach T, Seillier L, Saez-Rodriguez J, Dugourd AJF, Lehmann KV, Ben-Neriah Y, Gleitz HFE, Schneider RK. Fuchs SNR, et al. Among authors: haferlach t. Blood Adv. 2024 Feb 13;8(3):766-779. doi: 10.1182/bloodadvances.2022008926. Blood Adv. 2024. PMID: 38147624 Free PMC article.
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.
Choi IY, Ling JP, Zhang J, Helmenstine E, Walter W, Tsakiroglou P, Bergman RE, Philippe C, Manley JL, Rouault-Pierre K, Li B, Wiseman DH, Batta K, Ouseph MM, Bernard E, Dubner B, Li X, Haferlach T, Koget A, Fazal S, Jain T, Gocke CD, DeZern AE, Dalton WB. Choi IY, et al. Among authors: haferlach t. Blood Adv. 2024 May 17:bloodadvances.2023011260. doi: 10.1182/bloodadvances.2023011260. Online ahead of print. Blood Adv. 2024. PMID: 38759096
Genomic landscape of CCUS compared to MDS and its implications on risk prediction.
Huber S, Baer C, Hutter S, Wossidlo N, Hoermann G, Pohlkamp C, Walter W, Meggendorfer M, Kern W, Haferlach T, Haferlach C. Huber S, et al. Among authors: haferlach t. Leukemia. 2024 May 10. doi: 10.1038/s41375-024-02273-z. Online ahead of print. Leukemia. 2024. PMID: 38730270 No abstract available.
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation.
Gregorio C, Spreafico M, D'Amico S, Sauta E, Asti G, Lanino L, Tentori CA, Platzbecker U, Haferlach T, Diez-Campelo M, Fenaux P, Komrokji R, Della Porta MG, Ieva F. Gregorio C, et al. Among authors: haferlach t. JCO Clin Cancer Inform. 2024 May;8:e2300205. doi: 10.1200/CCI.23.00205. JCO Clin Cancer Inform. 2024. PMID: 38723213 Free article.
712 results